PULSE BIOSCIENCES, INC. Balance Sheet
PLSE / Health Care|12 years of annual SEC 10-K data (FY2014-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
PULSE BIOSCIENCES, INC. had $95M in total assets and $81M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $80.7M | $118.0M | $44.4M | $61.1M | $28.6M | $12.5M | $6.9M | $51.1M | $3.4M | $2.1M | $3.6M | $7.0M |
| Accounts Receivable | $274.0K | $0 | - | $0 | $61.0K | - | - | - | - | - | - | - |
| Inventory | $136.0K | $0 | - | $0 | $5.8M | - | - | - | - | - | - | - |
| Current Assets | $83.4M | $119.4M | $45.3M | $62.1M | $36.6M | $22.3M | $26.4M | $60.4M | $38.5M | $16.7M | $4.0M | - |
| PP&E (Net) | $1.1M | $1.2M | $1.5M | $2.0M | $2.5M | $2.5M | $2.6M | $2.2M | $2.6M | $317.0K | $329.0K | - |
| Goodwill | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | $2.8M | - |
| Total Assets | $94.5M | $132.5M | $59.2M | $77.9M | $54.2M | $41.3M | $41.9M | $70.6M | $49.8M | $26.3M | $14.3M | - |
| Current Liabilities | $7.9M | $10.1M | $6.7M | $6.0M | $8.5M | $7.6M | $4.5M | $3.1M | $2.2M | $1.0M | $660.0K | - |
| Shareholders' Equity | $80.7M | $114.9M | $35.7M | -$2.2M | $35.7M | $22.9M | $30.7M | $66.3M | $46.0M | $25.3M | $13.7M | $16.1M |